Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Shares Outstanding (Weighted Average) (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Shares Outstanding (Weighted Average) readings, the most recent being $8.5 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 64.37% to $8.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.5 million, a 64.37% increase, with the full-year FY2025 number at $100000.0, down 99.63% from a year prior.
  • Shares Outstanding (Weighted Average) hit $8.5 million in Q1 2026 for Neuroone Medical Technologies, down from $50.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $50.3 million in Q4 2025 to a low of $100000.0 in Q3 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $16.7 million (2023), compared with a mean of $20.6 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 71.87% in 2022 and later tumbled 99.63% in 2025.
  • Neuroone Medical Technologies' Shares Outstanding (Weighted Average) stood at $16.2 million in 2022, then surged by 47.84% to $24.0 million in 2023, then rose by 28.51% to $30.8 million in 2024, then skyrocketed by 63.21% to $50.3 million in 2025, then crashed by 83.14% to $8.5 million in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $8.5 million (Q1 2026), $50.3 million (Q4 2025), and $100000.0 (Q3 2025) per Business Quant data.